PLSEPulse Biosciences, Inc.
What is the market doing?
The market is with it: in an uptrend and insiders net buying.
In an uptrend, above its rising 50- and 200-day averages. Price is +96% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 8, 2026.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 0.6% since the previous count, up from 4.1% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PLSE is trading
Pulse Biosciences, Inc. is +206% over the past year while the S&P 500 is +18%: 187 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +96%
vs 200-day average · a clear uptrend
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 2.5%
Below its 52-week high
Details›
- Last close2026-10-09
- $53.80
- 1 monthS&P 500 +2.7%
- −1.1%
- 1 yearS&P 500 +18%
- +206%
- 5 yearsS&P 500 +88%
- +163%
- vs 50-day average$48.28
- +11%
- 52-week high
- $55.20
- 52-week low
- $12.66
- Annualised volatility
- 78%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $13M
| Year | Return |
|---|---|
| 2026 (year to date) | +292% |
| 2025 | −21% |
| 2024 | +42% |
| 2023 | +342% |
| 2022 | −81% |
| 2021 | −38% |
| 2020 | +78% |
| 2019 | +17% |
| 2018 | −51% |
| 2017 | +263% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.9% |
| Feb | 10 | 4 of 10 | +2.8% |
| Mar | 10 | 4 of 10 | +1.9% |
| Apr | 10 | 5 of 10 | +11% |
| May | 10 | 4 of 10 | +1.9% |
| Jun | 10 | 5 of 10 | +1.2% |
| Jul | 11 | 6 of 11 | +3.8% |
| Aug | 11 | 7 of 11 | +4.0% |
| Sep | 11 | 5 of 11 | +11% |
| Oct | 11 | 4 of 11 | +1.4% |
| Nov | 10 | 5 of 10 | +11% |
| Dec | 10 | 6 of 10 | +8.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #21 of 21 by RyuScore